CMS wants Part D plans to be on their best behavior

CMS will monitor whether plans increase the use of tools like prior authorization.

Related Keywords

United States ,China ,Ohio ,America ,Americans ,Carmen Paun ,Sam Whitaker ,Daniel Payne ,Phelps Mcnamara ,David Lim ,Zach Baron ,Cathy Mcmorris Rodgersr Wash ,Amanda Malakoff ,Michael Mccaulr Texas ,Bridgebio Pharma ,Julie Beitz ,Europe Varg Folkman ,Meena Seshamani ,Ilse Zuniga ,Meganr Wilson ,Robert King ,Johnsonr Ohio ,Arentfox Schiff ,Katherine Ellen Foley ,Supreme Court ,Us Chamber ,House Energy ,Astrazeneca ,Mural Health ,Law Initiative At Georgetown Oneill Institute ,Cigna ,Environmental Protection Agency ,European Commission On ,Woodward Pharma Services ,Sebela Pharmaceuticals ,B Health ,Plaintiff Merck Co Inc ,Rare Disease Company Coalition ,Arnold Porter ,Justice Department ,Cate Brandon ,United Healthcare ,Lauren Gardner ,Michael Mccaul ,Inflation Reduction Act ,Merck Sharp ,Plaintiff Merck ,Health Policy ,Law Initiative ,Troutman Pepper Strategies ,Capitol Hill ,Bio Pharma ,Commerce Environment ,Critical Materials Subcommittee ,Drug Evaluation ,European Commission ,Varg Folkman ,